G Medical Innovations Holdings Ltd. (GMVD) News
Filter GMVD News Items
GMVD News Results
|Loading, please wait...|
GMVD News Highlights
- For GMVD, its 30 day story count is now at 4.
- Over the past 16 days, the trend for GMVD's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- HOUR, LIND and PROF are the most mentioned tickers in articles about GMVD.
Latest GMVD News From Around the Web
Below are the latest news stories about G Medical Innovations Holdings Ltd that investors may wish to consider to help them evaluate GMVD as an investment opportunity.
G Medical Innovations Announces that More than 200,000 LiveNow At-Home COVID-19 PCR Tests are Now Available at 4,000+ Circle K Locations Nationally, with 300,000 More to Ship in the Coming Weeks
PCR collection kit tests provide 24–48-hour certified lab results and retail for $9.99
G Medical Innovations (NASDAQ:GMVD) continues to trade lower in the pre-market with a decline of ~2% following a selloff of more than 20% last Friday in reaction to the company’s announcement over a securities purchase agreement with Lind Global Fund II LP. Early this month, the company had disclosed a definitive securities purchase agreement...
G Medical Innovations (NASDAQ: GMVD) to Open One of the Largest COVID-19 Test Processing Labs and Walk-in Testing Facilities in the U.S.
The 26,000 sq ft site in Laguna, CA opens next week and will be able to process approximately 100,000 tests daily
G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company"), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical prof...
G Medical Innovations Joins Forces with Serology Covid Testing to Support Safer Classroom Learning in California School Districts Amid Omicron Variant Surge
On average, G Medical expects to collect an average of $197.88 per patient encounter, which could amount to more than $1,000,000 in gross revenue per week
G Medical Innovations Holdings (GMVD – Research Report) received a Buy rating and a $6.00 price target from EF Hutton analyst Constantine Davides on January 18. The company's shares closed last Wednesday at $6.12, close to its 52-week high of $6.74. According to TipRanks.com, Davides is ranked #4315 out of 7765 analysts. Currently, the analyst consensus on G Medical Innovations Holdings is a Moderate Buy with an average price target of $6.00. See the top stocks recommended by analysts >> TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions.
Good morning, trader!
Correction Notice to Press Release Regarding Personal Acquisitions of G Medical Shares in the Open Market
TEL AVIV and Pittsburgh, McDade Products, LLC and G Medical Tests and Services, a division of G Medical Innovations Holdings Ltd (NASDAQ: GMVD), announced today a correction to their press release ...
G Medical Innovations (NASDAQ: GMVD) is forecasting incremental Q1 revenues at around $30 MM, based on revenue generated from G Medical Tests and Services’ physical storefront testing locations
McDade Products, LLC and G Medical Innovations announce personal acquisitions of G Medical shares in the open market
McDade Products, LLC and G Medical Tests Secure Additional Purchase Order for $6.5 Million, Reflecting $3.5 Million Gross Margin, to be Delivered in Q1
G Medical Expands COVID-19 Testing Portfolio in Response to Omicron Variant, Distributes At-Home PCR Test Kits to Retail Stores Nationwide